304 related articles for article (PubMed ID: 16317914)
1. An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals.
Hector RF
Clin Tech Small Anim Pract; 2005 Nov; 20(4):240-9. PubMed ID: 16317914
[TBL] [Abstract][Full Text] [Related]
2. Antifungal therapy: potential interactions with other classes of drugs.
Bickers DR
J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S87-90. PubMed ID: 8077516
[TBL] [Abstract][Full Text] [Related]
3. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
4. Antifungal drugs.
Cross JT; Hickerson SL; Yamauchi T
Pediatr Rev; 1995 Apr; 16(4):123-9. PubMed ID: 7731906
[No Abstract] [Full Text] [Related]
5. [Antifungal agent resistance of yeasts of clinical significance].
Odds FC
Rev Clin Esp; 1995 Oct; 195 Suppl 3():56-7. PubMed ID: 9441307
[No Abstract] [Full Text] [Related]
6. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
7. Systemic antifungal drugs.
Med Lett Drugs Ther; 1994 Feb; 36(916):16-8. PubMed ID: 8302208
[No Abstract] [Full Text] [Related]
8. Drugs for treatment of fungal infections.
Med Lett Drugs Ther; 1992 Feb; 34(864):14-6. PubMed ID: 1310518
[No Abstract] [Full Text] [Related]
9. Fungal infections and their management.
Graybill JR; Sharkey PK
Br J Clin Pract Suppl; 1990 Sep; 71():23-31. PubMed ID: 1965416
[TBL] [Abstract][Full Text] [Related]
10. [Commonly used antifungal agents in the treatment of systemic mycoses].
Berenguer Berenguer J
Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
[No Abstract] [Full Text] [Related]
11. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Glasmacher A; Prentice AG
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of 115 isolates of Candida to amphotericin B, fluconazole and itraconazole.
Mallié M; Bastide JM
Drugs Exp Clin Res; 1996; 22(6):301-7. PubMed ID: 9034756
[TBL] [Abstract][Full Text] [Related]
14. Antifungal treatment in patients with cancer.
Viscoli C; Castagnola E; Machetti M
J Intern Med Suppl; 1997; 740():89-94. PubMed ID: 9350188
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the treatment of systemic fungal infections.
Walsh TJ
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
[TBL] [Abstract][Full Text] [Related]
16. Antifungal treatment of small animal veterinary patients.
Foy DS; Trepanier LA
Vet Clin North Am Small Anim Pract; 2010 Nov; 40(6):1171-88. PubMed ID: 20933143
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility testing of fungi and correlation with clinical outcome.
Ghannoum MA
J Chemother; 1997 May; 9 Suppl 1():19-24. PubMed ID: 9248959
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of in vitro antifungal susceptibility testing.
Espinel-Ingroff A
Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
[TBL] [Abstract][Full Text] [Related]
19. [Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
Alvarado D; Díaz MC; Silva V
Rev Med Chil; 2002 Apr; 130(4):416-23. PubMed ID: 12090107
[TBL] [Abstract][Full Text] [Related]
20. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole].
Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT
Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
